No Prescription |
 |
 | ||
|
Thioprine Imuran |
|
| ||
No Prescription » Prescription Drugs 16 » Thioprine Imuran IndicationsAzathioprine is used as an immunosuppressant antimetabolite either alone or more commonly in combination with other agents (usually corticosteroids) and procedures which influence the immune response. Therapeutic effect may be evident only after weeks or months and can include a steroid-sparing effect thereby reducing the toxicity associated with high dosage and prolonged usage of corticosteroids.Azathioprine in combination with corticosteroids and/or other immunosuppressive agents and procedures is indicated to enhance the survival of organ transplants such as renal transplants cardiac transplants and hepatic transplants; and to reduce the corticosteroid requirements of renal transplant recipients.Azathioprine is indicated for the treatment of moderate to severe Crohn's disease in patients in whom corticosteroid therapy is required in patients who cannot tolerate corticosteroid therapy or in patients whose disease is refractory to other standard first line therapy.Azathioprine either alone or more usually in combination with corticosteroids and/or other medicines and procedures has been used with clinical benefit (which may include reduction of dosage or discontinuation of corticosteroids) in a proportion of patients suffering from the following:severe rheumatoid arthritis; systemic lupus erythematosus; dermatomyositis and polymyositis; auto-immune chronic active hepatitis; pemphigus vulgaris; polyarteritis nodosa; auto-immune haemolytic anaemia; chronic refractory idiopathic thrombocytopenic purpura; ulcerative colitis. Buy Thioprine Imuran and other Prescription Drugs 16 products online at Medstore. Buy Online at Medstore - Click Here!
About Thioprine Imuran: Product Type: Prescription Drugs 16 Thioprine ( Imuran Generic Azathioprine ) Thioprine (Imuran Generic Azathioprine) Imuran Generic Azathioprine 50mg Imuran Generic Azathioprine Thioprine
View more Prescription Drugs 16 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
